News Stories

The U.S. Food and Drug Administration released a Drug Safety Communication on July 20, 2021, concerning the removal of the strongest warning against using statins during pregnancy. The warning states that statins should never be used in any patients during pregnancy.

JACKSONVILLE, Fla. and ORANGEBURG, N.Y., March 02, 2021 -- The National Lipid Association (NLA), the preeminent global authority on lipid disorders, and Paradigm Medical Communications, LLC (Paradigm), a multiple award-winning medical education company, are proud to announce their collaborative partnership to design and implement How Low Do You Go? Novel Strategies to Address LDL-C Limbo, an 18-month blended learning, certified continuing education curriculum for clinicians, comprising live and online activities, to launch in May 2021.

Be sure to make plans to join us in June (VIRTUALLY) and September (IN-PERSON) for our premier educational events in 2021:

Summer of Lipids: A Virtual Education Experience with the NLA · June 4-6, 2021